Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection
Clinical trial NCT00300274 · COMPLETED
Trial details
- NCT number
- NCT00300274
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2011-07-01
- Enrollment
- 721
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.